Pete O'Heeron - 02 Mar 2026 Form 4 Insider Report for FibroBiologics, Inc. (FBLG)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: FBLG
Reported as of: 02 Mar 2026
Net transaction value: +$19,531
SEC form: 4
Accepted by SEC: 04 Mar 2026, 17:50:10 UTC
Prior SEC filing: 22 Aug 2025
Next SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Ruben A. Garcia, by Power of Attorney

Key filing fact

Pete O'Heeron filed Form 4 for FibroBiologics, Inc. (FBLG) on 04 Mar 2026.

Key facts

This page summarizes Pete O'Heeron's Form 4 filing for FibroBiologics, Inc. (FBLG).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2026, 17:50.

Change

Previous filing in this sequence was filed on 22 Aug 2025.
Current net transaction value: +$19,531.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001569334 Primary reporting owner

O'HEERON PETE

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O FIBROBIOLOGICS, INC., 455 E. MEDICAL CENTER BLVD., SUITE 300, HOUSTON
Signature: /s/ Ruben A. Garcia, by Power of Attorney
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBLG transaction

Common Stock

Purchase

Transaction value: $6,152
Shares: +17,428
Change %: +0.3%
Price: $0.3530
Shares after: 5,924,075
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

FBLG transaction

Common Stock

Purchase

Transaction value: $7,373
Shares: +18,200
Change %: +0.31%
Price: $0.4051
Shares after: 5,942,275
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

FBLG transaction

Common Stock

Purchase

Transaction value: $6,006
Shares: +15,872
Change %: +0.27%
Price: $0.3784
Shares after: 5,958,147
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.